Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Addison's Disease Treatment market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Addison's Disease Treatmentmarket, defines the market attractiveness level of Addison's Disease Treatment market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Addison's Disease Treatment industry, describes the types of Addison's Disease Treatment market, the applications of major players and the market size, and deeply analyzes the current situation of the global Addison's Disease Treatment market and the development prospects and opportunities of Addison's Disease Treatment industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Addison's Disease Treatment market in Chapter 13.
By Player:
Hikma Pharmaceuticals Plc
Merck & Co Inc
Novartis AG
Pfizer Inc
Bristol-Myers Squibb Co
Actiza Pharmaceutical Pvt Ltd
Takeda Pharmaceutical Co Ltd
Amneal Pharmaceuticals Inc
Akorn Inc
Diurnal Group Plc
By Type:
Oral Corticosteroid
Corticosteroid Injections
By End-User:
Hospitals
Clinics
Others
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Addison's Disease Treatment Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Addison's Disease Treatment Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Addison's Disease Treatment Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Addison's Disease Treatment Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Addison's Disease Treatment Market Analysis and Outlook to 2022
-
7.1 Global Addison's Disease Treatment Consumption (2017-2022)
-
7.2 United States Addison's Disease Treatment Consumption (2017-2022)
-
7.3 Europe Addison's Disease Treatment Consumption (2017-2022)
-
7.4 China Addison's Disease Treatment Consumption (2017-2022)
-
7.5 Japan Addison's Disease Treatment Consumption (2017-2022)
-
7.6 India Addison's Disease Treatment Consumption (2017-2022)
-
7.7 South Korea Addison's Disease Treatment Consumption (2017-2022)
8 Region and Country-wise Addison's Disease Treatment Market Analysis and Outlook to 2028
-
8.1 Global Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.2 United States Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.3 Europe Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.4 China Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.5 Japan Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.6 India Addison's Disease Treatment Consumption Forecast (2022-2028)
-
8.7 South Korea Addison's Disease Treatment Consumption Forecast (2022-2028)
9 Global Addison's Disease Treatment Market Outlook by Types and Applications to 2022
-
9.1 Global Addison's Disease Treatment Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global Oral Corticosteroid Consumption and Growth Rate (2017-2022)
-
9.1.2 Global Corticosteroid Injections Consumption and Growth Rate (2017-2022)
-
9.2 Global Addison's Disease Treatment Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Others Consumption and Growth Rate (2017-2022)
10 Global Addison's Disease Treatment Market Outlook by Types and Applications to 2028
-
10.1 Global Addison's Disease Treatment Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global Oral Corticosteroid Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global Corticosteroid Injections Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Addison's Disease Treatment Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Others Consumption Forecast and Growth Rate (2022-2028)
11 Global Addison's Disease Treatment Import and Export Analysis (Top 5 Countries)
-
11.1 Global Addison's Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Addison's Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Addison's Disease Treatment Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Addison's Disease Treatment Market Competitive Analysis
-
14.1 Hikma Pharmaceuticals Plc
-
14.1.1 Hikma Pharmaceuticals Plc Company Details
-
14.1.2 Hikma Pharmaceuticals Plc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Hikma Pharmaceuticals Plc Addison's Disease Treatment Product and Service
-
14.2 Merck & Co Inc
-
14.2.1 Merck & Co Inc Company Details
-
14.2.2 Merck & Co Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Merck & Co Inc Addison's Disease Treatment Product and Service
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Details
-
14.3.2 Novartis AG Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Novartis AG Addison's Disease Treatment Product and Service
-
14.4 Pfizer Inc
-
14.4.1 Pfizer Inc Company Details
-
14.4.2 Pfizer Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Pfizer Inc Addison's Disease Treatment Product and Service
-
14.5 Bristol-Myers Squibb Co
-
14.5.1 Bristol-Myers Squibb Co Company Details
-
14.5.2 Bristol-Myers Squibb Co Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Bristol-Myers Squibb Co Addison's Disease Treatment Product and Service
-
14.6 Actiza Pharmaceutical Pvt Ltd
-
14.6.1 Actiza Pharmaceutical Pvt Ltd Company Details
-
14.6.2 Actiza Pharmaceutical Pvt Ltd Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Actiza Pharmaceutical Pvt Ltd Addison's Disease Treatment Product and Service
-
14.7 Takeda Pharmaceutical Co Ltd
-
14.7.1 Takeda Pharmaceutical Co Ltd Company Details
-
14.7.2 Takeda Pharmaceutical Co Ltd Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Takeda Pharmaceutical Co Ltd Addison's Disease Treatment Product and Service
-
14.8 Amneal Pharmaceuticals Inc
-
14.8.1 Amneal Pharmaceuticals Inc Company Details
-
14.8.2 Amneal Pharmaceuticals Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 Amneal Pharmaceuticals Inc Addison's Disease Treatment Product and Service
-
14.9 Akorn Inc
-
14.9.1 Akorn Inc Company Details
-
14.9.2 Akorn Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Akorn Inc Addison's Disease Treatment Product and Service
-
14.10 Diurnal Group Plc
-
14.10.1 Diurnal Group Plc Company Details
-
14.10.2 Diurnal Group Plc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Diurnal Group Plc Addison's Disease Treatment Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Addison's Disease Treatment
-
Figure Addison's Disease Treatment Picture
-
Table Global Addison's Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Addison's Disease Treatment Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Addison's Disease Treatment Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Addison's Disease Treatment Consumption by Country (2017-2022)
-
Figure United States Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Table Europe Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure China Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Japan Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure India Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure South Korea Addison's Disease Treatment Consumption and Growth Rate (2017-2022)
-
Figure Global Addison's Disease Treatment Consumption Forecast by Country (2022-2028)
-
Figure United States Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Addison's Disease Treatment Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Oral Corticosteroid Consumption and Growth Rate (2017-2022)
-
Figure Global Corticosteroid Injections Consumption and Growth Rate (2017-2022)
-
Figure Global Hospitals Consumption and Growth Rate (2017-2022)
-
Figure Global Clinics Consumption and Growth Rate (2017-2022)
-
Figure Global Others Consumption and Growth Rate (2017-2022)
-
Figure Global Oral Corticosteroid Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Corticosteroid Injections Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Others Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Addison's Disease Treatment Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Addison's Disease Treatment Export by Region (Top 5 Countries) (2017-2028)
-
Table Hikma Pharmaceuticals Plc (Foundation Year, Company Profile and etc.)
-
Table Hikma Pharmaceuticals Plc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hikma Pharmaceuticals Plc Addison's Disease Treatment Product and Service
-
Table Merck & Co Inc (Foundation Year, Company Profile and etc.)
-
Table Merck & Co Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Merck & Co Inc Addison's Disease Treatment Product and Service
-
Table Novartis AG (Foundation Year, Company Profile and etc.)
-
Table Novartis AG Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Novartis AG Addison's Disease Treatment Product and Service
-
Table Pfizer Inc (Foundation Year, Company Profile and etc.)
-
Table Pfizer Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Pfizer Inc Addison's Disease Treatment Product and Service
-
Table Bristol-Myers Squibb Co (Foundation Year, Company Profile and etc.)
-
Table Bristol-Myers Squibb Co Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Bristol-Myers Squibb Co Addison's Disease Treatment Product and Service
-
Table Actiza Pharmaceutical Pvt Ltd (Foundation Year, Company Profile and etc.)
-
Table Actiza Pharmaceutical Pvt Ltd Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Actiza Pharmaceutical Pvt Ltd Addison's Disease Treatment Product and Service
-
Table Takeda Pharmaceutical Co Ltd (Foundation Year, Company Profile and etc.)
-
Table Takeda Pharmaceutical Co Ltd Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Takeda Pharmaceutical Co Ltd Addison's Disease Treatment Product and Service
-
Table Amneal Pharmaceuticals Inc (Foundation Year, Company Profile and etc.)
-
Table Amneal Pharmaceuticals Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Amneal Pharmaceuticals Inc Addison's Disease Treatment Product and Service
-
Table Akorn Inc (Foundation Year, Company Profile and etc.)
-
Table Akorn Inc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Akorn Inc Addison's Disease Treatment Product and Service
-
Table Diurnal Group Plc (Foundation Year, Company Profile and etc.)
-
Table Diurnal Group Plc Addison's Disease Treatment Sales, Price, Value and Gross Profit (2017-2022)
-
Table Diurnal Group Plc Addison's Disease Treatment Product and Service
-
